The following information appeared on, cms.gov
Effective July 1, 2022, CMS added J1551 JB (Injection, immune globulin (cutaquig), 100mg) to payment category 2 (PDF).
CMS assigns home infusion drugs to 3 pay-ment categories, as determined by the HCPCS J-Code.
- Payment Category 1 includes certain intravenous antifungals and antivirals, uninterrupted long-term infusions, pain management, inotropic, chelation drugs.
- Payment Category 2 includes subcutaneous immunotherapy and other certain subcutaneous infusion drugs.
- Payment Category 3 includes certain chemotherapy drugs.
